tykhr
sign in
free sign up
Dicerna Pharmaceuticals Inc
Biotechnology
Healthcare
DRNA
77.03M shares
NASDAQ US
traded
27 Dec 2021
open
38.21
52 week high
39.99
high
38.24
52 week low
19.26
low
38.21
growth
64.1%
previous Close
38.00
P/E ratio
-174
market cap
1.74B
div yield
0
usd
Sep 2021
qoq
revenue
62.95M
52.29 %
net incoming
-17.07M
58.17 %
eps
-0.22
58.49 %
eps surprise
52.17 %
net profit margin
-27.12 %
71.00 %
operating incoming
-20.27M
49.63 %
net change in cash
-55.45M
-189.30 %
cash on hand
166M
-25.07 %
cost of revenue
top